Literature DB >> 29722113

Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?

Konstantinos Stavropoulos1, Konstantinos P Imprialos1, Niki Katsiki1, Konstantinos Petidis1, Apostolos Kamparoudis2, Panagiotis Petras2, Vasiliki Georgopoulou3, Stefanos Finitsis4, Christodoulos Papadopoulos5, Vasilios G Athyros1, Michael Doumas1,6, Asterios Karagiannis1.   

Abstract

Primary aldosteronism (PA) is a common form of secondary hypertension. Several guidelines recommend that patients with adrenal incidentaloma have a high probability of suffering from PA. We conducted a prospective study of 269 consecutive adults with adrenal incidentaloma to investigate the prevalence and clinical characteristics of PA. In total, 9 participants were detected with PA, suggesting a prevalence of 3.35% among the study population. PA participants had a higher blood pressure level by 14/20.8 mm Hg and a lower serum potassium level by 0.8 mmol/L (P < .05). Importantly, all patients with PA presented with concurrent indications (hypertension with or without hypokalemia) for screening of the disease, but they have not undergone relative screening by the referring physician, thus casting doubts about the appropriate implementation of current guidelines in real-life practice. Intense efforts are needed to familiarize physicians with recommendations for PA to minimize undiagnosed cases and the detrimental sequelae of this endocrine form of hypertension. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  adrenal incidentaloma; hypertension; hypokalemia; primary aldosteronism; resistant hypertension

Mesh:

Substances:

Year:  2018        PMID: 29722113      PMCID: PMC8031295          DOI: 10.1111/jch.13291

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  39 in total

1.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

Authors:  Stella Douma; Konstantinos Petidis; Michael Doumas; Panagiota Papaefthimiou; Areti Triantafyllou; Niki Kartali; Nikolaos Papadopoulos; Konstantinos Vogiatzis; Chrysanthos Zamboulis
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

2.  Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.

Authors:  S Bovio; A Cataldi; G Reimondo; P Sperone; S Novello; A Berruti; P Borasio; C Fava; L Dogliotti; G V Scagliotti; A Angeli; M Terzolo
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

3.  Management of the clinically inapparent adrenal mass ("incidentaloma").

Authors:  Melvin M Grumbach; Beverly M K Biller; Glenn D Braunstein; Karen K Campbell; J Aidan Carney; Paul A Godley; Emily L Harris; Joseph K T Lee; Yolanda C Oertel; Mitchell C Posner; Janet A Schlechte; H Samuel Wieand
Journal:  Ann Intern Med       Date:  2003-03-04       Impact factor: 25.391

4.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

5.  Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.

Authors:  Asterios Karagiannis; Konstantinos Tziomalos; Athanasios Papageorgiou; Anna I Kakafika; Efstathios D Pagourelias; Panagiotis Anagnostis; Vasilios G Athyros; Dimitri P Mikhailidis
Journal:  Expert Opin Pharmacother       Date:  2008-03       Impact factor: 3.889

6.  The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.

Authors:  M Tzanela; G Effraimidis; G Effremidis; D Vassiliadi; A Szabo; N Gavalas; A Valatsou; E Botoula; N C Thalassinos
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

7.  Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-18       Impact factor: 3.738

8.  Screening for Primary Aldosteronism: Whom and How?

Authors:  Michael Doumas; Vasilios Athyros; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

Review 9.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

10.  Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Niki Katsiki; Konstantinos Petidis; Apostolos Kamparoudis; Panagiotis Petras; Vasiliki Georgopoulou; Stefanos Finitsis; Christodoulos Papadopoulos; Vasilios G Athyros; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-02       Impact factor: 3.738

View more
  2 in total

Review 1.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

2.  Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Niki Katsiki; Konstantinos Petidis; Apostolos Kamparoudis; Panagiotis Petras; Vasiliki Georgopoulou; Stefanos Finitsis; Christodoulos Papadopoulos; Vasilios G Athyros; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-02       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.